The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Vaccines & Therapeutics Market Research Report 2025
Synopsis
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global mRNA Vaccines & Therapeutics market was valued at US$ 36680 million in 2023 and is anticipated to reach US$ 1575.4 million by 2030, witnessing a CAGR of -14.0% during the forecast period 2024-2030.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics.
Report Scope
The mRNA Vaccines & Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccines & Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines & Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Vaccines & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global mRNA Vaccines & Therapeutics market was valued at US$ 36680 million in 2023 and is anticipated to reach US$ 1575.4 million by 2030, witnessing a CAGR of -14.0% during the forecast period 2024-2030.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics.
Report Scope
The mRNA Vaccines & Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccines & Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines & Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Vaccines & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 mRNA Vaccines & Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 mRNA Vaccines & Therapeutics Segment by Type
1.2.1 Global mRNA Vaccines & Therapeutics Market Value Comparison by Type (2024-2030)
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 mRNA Vaccines & Therapeutics Segment by Application
1.3.1 Global mRNA Vaccines & Therapeutics Market Value by Application: (2024-2030)
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Global mRNA Vaccines & Therapeutics Market Size Estimates and Forecasts
1.4.1 Global mRNA Vaccines & Therapeutics Revenue 2019-2030
1.4.2 Global mRNA Vaccines & Therapeutics Sales 2019-2030
1.4.3 Global mRNA Vaccines & Therapeutics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 mRNA Vaccines & Therapeutics Market Competition by Manufacturers
2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2019-2024)
2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2019-2024)
2.4 Global mRNA Vaccines & Therapeutics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
2.7 mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
2.7.1 mRNA Vaccines & Therapeutics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest mRNA Vaccines & Therapeutics Players Market Share by Revenue
2.7.3 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region
3.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global mRNA Vaccines & Therapeutics Global mRNA Vaccines & Therapeutics Sales by Region: 2019-2030
3.2.1 Global mRNA Vaccines & Therapeutics Sales by Region: 2019-2024
3.2.2 Global mRNA Vaccines & Therapeutics Sales by Region: 2025-2030
3.3 Global mRNA Vaccines & Therapeutics Global mRNA Vaccines & Therapeutics Revenue by Region: 2019-2030
3.3.1 Global mRNA Vaccines & Therapeutics Revenue by Region: 2019-2024
3.3.2 Global mRNA Vaccines & Therapeutics Revenue by Region: 2025-2030
3.4 North America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.4.1 North America mRNA Vaccines & Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America mRNA Vaccines & Therapeutics Sales by Country (2019-2030)
3.4.3 North America mRNA Vaccines & Therapeutics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.5.1 Europe mRNA Vaccines & Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe mRNA Vaccines & Therapeutics Sales by Country (2019-2030)
3.5.3 Europe mRNA Vaccines & Therapeutics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.6.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific mRNA Vaccines & Therapeutics Sales by Country (2019-2030)
3.6.3 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.7.1 Latin America mRNA Vaccines & Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America mRNA Vaccines & Therapeutics Sales by Country (2019-2030)
3.7.3 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2019-2030)
3.8.3 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global mRNA Vaccines & Therapeutics Sales by Type (2019-2030)
4.1.1 Global mRNA Vaccines & Therapeutics Sales by Type (2019-2024)
4.1.2 Global mRNA Vaccines & Therapeutics Sales by Type (2025-2030)
4.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2019-2030)
4.2.1 Global mRNA Vaccines & Therapeutics Revenue by Type (2019-2024)
4.2.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2025-2030)
4.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global mRNA Vaccines & Therapeutics Price by Type (2019-2030)
5 Segment by Application
5.1 Global mRNA Vaccines & Therapeutics Sales by Application (2019-2030)
5.1.1 Global mRNA Vaccines & Therapeutics Sales by Application (2019-2024)
5.1.2 Global mRNA Vaccines & Therapeutics Sales by Application (2025-2030)
5.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2019-2030)
5.2.1 Global mRNA Vaccines & Therapeutics Revenue by Application (2019-2024)
5.2.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2025-2030)
5.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global mRNA Vaccines & Therapeutics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Moderna Therapeutics
6.1.1 Moderna Therapeutics Corporation Information
6.1.2 Moderna Therapeutics Description and Business Overview
6.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.1.5 Moderna Therapeutics Recent Developments/Updates
6.2 CureVac
6.2.1 CureVac Corporation Information
6.2.2 CureVac Description and Business Overview
6.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
6.2.5 CureVac Recent Developments/Updates
6.3 Translate Bio
6.3.1 Translate Bio Corporation Information
6.3.2 Translate Bio Description and Business Overview
6.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
6.3.5 Translate Bio Recent Developments/Updates
6.4 BioNTech
6.4.1 BioNTech Corporation Information
6.4.2 BioNTech Description and Business Overview
6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
6.4.5 BioNTech Recent Developments/Updates
6.5 Sangamo Therapeutics
6.5.1 Sangamo Therapeutics Corporation Information
6.5.2 Sangamo Therapeutics Description and Business Overview
6.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.5.5 Sangamo Therapeutics Recent Developments/Updates
6.6 Argos Therapeutics
6.6.1 Argos Therapeutics Corporation Information
6.6.2 Argos Therapeutics Description and Business Overview
6.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.6.5 Argos Therapeutics Recent Developments/Updates
6.7 In-Cell-Art
6.6.1 In-Cell-Art Corporation Information
6.6.2 In-Cell-Art Description and Business Overview
6.6.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
6.7.5 In-Cell-Art Recent Developments/Updates
6.8 eTheRNA
6.8.1 eTheRNA Corporation Information
6.8.2 eTheRNA Description and Business Overview
6.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
6.8.5 eTheRNA Recent Developments/Updates
6.9 Ethris
6.9.1 Ethris Corporation Information
6.9.2 Ethris Description and Business Overview
6.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
6.9.5 Ethris Recent Developments/Updates
6.10 Tiba Biotechnology
6.10.1 Tiba Biotechnology Corporation Information
6.10.2 Tiba Biotechnology Description and Business Overview
6.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
6.10.5 Tiba Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Vaccines & Therapeutics Industry Chain Analysis
7.2 mRNA Vaccines & Therapeutics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Vaccines & Therapeutics Production Mode & Process
7.4 mRNA Vaccines & Therapeutics Sales and Marketing
7.4.1 mRNA Vaccines & Therapeutics Sales Channels
7.4.2 mRNA Vaccines & Therapeutics Distributors
7.5 mRNA Vaccines & Therapeutics Customers
8 mRNA Vaccines & Therapeutics Market Dynamics
8.1 mRNA Vaccines & Therapeutics Industry Trends
8.2 mRNA Vaccines & Therapeutics Market Drivers
8.3 mRNA Vaccines & Therapeutics Market Challenges
8.4 mRNA Vaccines & Therapeutics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global mRNA Vaccines & Therapeutics Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global mRNA Vaccines & Therapeutics Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global mRNA Vaccines & Therapeutics Market Competitive Situation by Manufacturers in 2023
Table 4. Global mRNA Vaccines & Therapeutics Sales (M Doses) of Key Manufacturers (2019-2024)
Table 5. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 6. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market mRNA Vaccines & Therapeutics Average Price (USD/Doses) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of mRNA Vaccines & Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
Table 12. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines & Therapeutics as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Vaccines & Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global mRNA Vaccines & Therapeutics Sales by Region (2019-2024) & (M Doses)
Table 18. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2019-2024)
Table 19. Global mRNA Vaccines & Therapeutics Sales by Region (2025-2030) & (M Doses)
Table 20. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2025-2030)
Table 21. Global mRNA Vaccines & Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2019-2024)
Table 23. Global mRNA Vaccines & Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2025-2030)
Table 25. North America mRNA Vaccines & Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America mRNA Vaccines & Therapeutics Sales by Country (2019-2024) & (M Doses)
Table 27. North America mRNA Vaccines & Therapeutics Sales by Country (2025-2030) & (M Doses)
Table 28. North America mRNA Vaccines & Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America mRNA Vaccines & Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe mRNA Vaccines & Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe mRNA Vaccines & Therapeutics Sales by Country (2019-2024) & (M Doses)
Table 32. Europe mRNA Vaccines & Therapeutics Sales by Country (2025-2030) & (M Doses)
Table 33. Europe mRNA Vaccines & Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe mRNA Vaccines & Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2019-2024) & (M Doses)
Table 37. Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2025-2030) & (M Doses)
Table 38. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America mRNA Vaccines & Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America mRNA Vaccines & Therapeutics Sales by Country (2019-2024) & (M Doses)
Table 42. Latin America mRNA Vaccines & Therapeutics Sales by Country (2025-2030) & (M Doses)
Table 43. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2019-2024) & (M Doses)
Table 47. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2025-2030) & (M Doses)
Table 48. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2019-2024)
Table 51. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2025-2030)
Table 52. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2019-2024)
Table 53. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2025-2030)
Table 54. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) by Type (2019-2024)
Table 55. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) by Type (2025-2030)
Table 56. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2019-2024)
Table 57. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2025-2030)
Table 58. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Type (2019-2024)
Table 59. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Type (2025-2030)
Table 60. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2019-2024)
Table 61. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2025-2030)
Table 62. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2019-2024)
Table 63. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2025-2030)
Table 64. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) by Application (2019-2024)
Table 65. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) by Application (2025-2030)
Table 66. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2019-2024)
Table 67. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2025-2030)
Table 68. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Application (2019-2024)
Table 69. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Application (2025-2030)
Table 70. Moderna Therapeutics Corporation Information
Table 71. Moderna Therapeutics Description and Business Overview
Table 72. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 73. Moderna Therapeutics mRNA Vaccines & Therapeutics Product
Table 74. Moderna Therapeutics Recent Developments/Updates
Table 75. CureVac Corporation Information
Table 76. CureVac Description and Business Overview
Table 77. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 78. CureVac mRNA Vaccines & Therapeutics Product
Table 79. CureVac Recent Developments/Updates
Table 80. Translate Bio Corporation Information
Table 81. Translate Bio Description and Business Overview
Table 82. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 83. Translate Bio mRNA Vaccines & Therapeutics Product
Table 84. Translate Bio Recent Developments/Updates
Table 85. BioNTech Corporation Information
Table 86. BioNTech Description and Business Overview
Table 87. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 88. BioNTech mRNA Vaccines & Therapeutics Product
Table 89. BioNTech Recent Developments/Updates
Table 90. Sangamo Therapeutics Corporation Information
Table 91. Sangamo Therapeutics Description and Business Overview
Table 92. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 93. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
Table 94. Sangamo Therapeutics Recent Developments/Updates
Table 95. Argos Therapeutics Corporation Information
Table 96. Argos Therapeutics Description and Business Overview
Table 97. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 98. Argos Therapeutics mRNA Vaccines & Therapeutics Product
Table 99. Argos Therapeutics Recent Developments/Updates
Table 100. In-Cell-Art Corporation Information
Table 101. In-Cell-Art Description and Business Overview
Table 102. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 103. In-Cell-Art mRNA Vaccines & Therapeutics Product
Table 104. In-Cell-Art Recent Developments/Updates
Table 105. eTheRNA Corporation Information
Table 106. eTheRNA Description and Business Overview
Table 107. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 108. eTheRNA mRNA Vaccines & Therapeutics Product
Table 109. eTheRNA Recent Developments/Updates
Table 110. Ethris Corporation Information
Table 111. Ethris Description and Business Overview
Table 112. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 113. Ethris mRNA Vaccines & Therapeutics Product
Table 114. Ethris Recent Developments/Updates
Table 115. Tiba Biotechnology Corporation Information
Table 116. Tiba Biotechnology Description and Business Overview
Table 117. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 118. Tiba Biotechnology mRNA Vaccines & Therapeutics Product
Table 119. Tiba Biotechnology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. mRNA Vaccines & Therapeutics Distributors List
Table 123. mRNA Vaccines & Therapeutics Customers List
Table 124. mRNA Vaccines & Therapeutics Market Trends
Table 125. mRNA Vaccines & Therapeutics Market Drivers
Table 126. mRNA Vaccines & Therapeutics Market Challenges
Table 127. mRNA Vaccines & Therapeutics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of mRNA Vaccines & Therapeutics
Figure 2. Global mRNA Vaccines & Therapeutics Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global mRNA Vaccines & Therapeutics Market Share by Type in 2023 & 2030
Figure 4. Infectious Disease Vaccines Product Picture
Figure 5. Cancer Vaccines Product Picture
Figure 6. Global mRNA Vaccines & Therapeutics Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global mRNA Vaccines & Therapeutics Market Share by Application in 2023 & 2030
Figure 8. Infectious Disease
Figure 9. Cancer
Figure 10. Global mRNA Vaccines & Therapeutics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global mRNA Vaccines & Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 12. Global mRNA Vaccines & Therapeutics Sales (2019-2030) & (M Doses)
Figure 13. Global mRNA Vaccines & Therapeutics Average Price (USD/Doses) & (2019-2030)
Figure 14. mRNA Vaccines & Therapeutics Report Years Considered
Figure 15. mRNA Vaccines & Therapeutics Sales Share by Manufacturers in 2023
Figure 16. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest mRNA Vaccines & Therapeutics Players: Market Share by Revenue in 2023
Figure 18. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global mRNA Vaccines & Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2019-2030)
Figure 21. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2019-2030)
Figure 22. United States mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2019-2030)
Figure 25. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2019-2030)
Figure 26. Germany mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region (2019-2030)
Figure 33. China mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Country (2019-2030)
Figure 43. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2019-2030)
Figure 44. Mexico mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2019-2030)
Figure 49. Turkey mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE mRNA Vaccines & Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of mRNA Vaccines & Therapeutics by Type (2019-2030)
Figure 53. Global Revenue Market Share of mRNA Vaccines & Therapeutics by Type (2019-2030)
Figure 54. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Type (2019-2030)
Figure 55. Global Sales Market Share of mRNA Vaccines & Therapeutics by Application (2019-2030)
Figure 56. Global Revenue Market Share of mRNA Vaccines & Therapeutics by Application (2019-2030)
Figure 57. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Application (2019-2030)
Figure 58. mRNA Vaccines & Therapeutics Value Chain
Figure 59. mRNA Vaccines & Therapeutics Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
